Ayodhya priest arrested for holding devotee hostage, raping her several times

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

New Delhi, Feb 9: Calling India a "long-standing friend", Sri Lankan Prime Minister Mahinda Rajapaksa on Saturday thanked Prime Minister Narendra Modi for visiting his country in the aftermath of last year's Easter Sunday terror attacks and outlined that New Delhi has always helped Colombo in its fight against terrorism.

In a joint press briefing with PM Modi, Mahinda Rajapaksa said he hopes that India will continue to help Sri Lanka fight terrorism.

Mahinda Rajapaksa expressed his gratitude to PM Modi for the neighbourhood first policy and the priority India gives to Sri Lanka.

"We had agreed that our cooperation is multifaceted and priority is given to a number of areas including security, economy, culture and social sectors. Part of our discussions centered on cooperation with regard to the security of the two countries. India has always assisted Sri Lanka to enhance our capacity, capabilities in intelligence and counter-terrorism. We look forward to getting continued support in this regard," he said.

"I thank the Prime Minister for visiting Sri Lanka in the aftermath of the Easter Sunday terror attacks that provided us with immense strength to come to terms with the tragedy. We also appreciate Prime Minister Modi's $400 million line of credit to enhance the economy of Sri Lanka and another $50 million line of credit for fighting terrorism," he added.

The Sri Lankan president urged PM Modi to consider further assistance to expand housing projectS all over Sri Lanka to benefit people from rural areas.

"The Prime Minister and I discussed how Sri Lanka and India can work together in the field of economy. India is among the world's fastest growing economies. I discussed with PM Modi how Sri Lanka could benefit from certain economic sectors where India is in a strong position," he said.

Concluding his statement, Mahinda Rajapaksa said, "India is our closest neighbour and a long-standing friend. The close historical links...provided a solid foundation to our ties."

Lucknow, Jun 7: From Anamika Shukla to Anamika Singh and finally Priya. The primary school teacher who was found to be teaching simultaneously in 25 schools, not only has multiple jobs but also multiple identities.

Anamika was arrested on Saturday from Kasganj district when she went to submit her resignation after she was served a show cause notice by the Basic Shiksha Adhikari (BSA), Anjali Agarwal.

Agarwal informed the police and Anamika was arrested.

According to the Kasganj BSA, Anamika Shukla, originally a resident of Kaimganj in Farukhabad is currently doing her B.Ed from the Raghukul Degree College in Gonda. Her other documents are also from the same college.

During interrogation, Anamika Shukla said that she was actually Anamika Singh but as questioning proceeded, it turned out that she was Priya from Farrukhabad.

She has been booked for cheating and forgery under IPC sections 420 (cheating and dishonestly inducing delivery of property), 467 (forgery of valuable security, will etc.) and 468 (forgery for purpose of cheating).

According to the police, the woman claimed that she had paid Rs five lakh to a Mainpuri-based man to get this job.

She used Anamika Shukla's credentials to get the job while her real name is Priya, daughter of Mahipal, a resident of the Lakhanpur village of the Kayamganj police circle in Farrukhabad district.

Soron station house officer (SHO) Ripudaman Singh said, "During interrogation, the accused initially claimed to be Anamika Singh, daughter of Subhas Singh. However, her documents are in the name of Anamika Shukla, daughter of Subhas Chandra Shukla."

The accused claimed that she paid the hefty amount to Raj, a Mainpuri-based man for the job and was posted in Faridpur Kasturba Gandhi Balika Vidyalaya (KGBV) since August 2018.

The police are now trying to zero in on the man who got her the job.

The police also believe that it could be possible that multiple candidates used credentials and 'eligibility' of Anamika Shukla - the real one still remains elusive.

According to the Uttar Pradesh government, five more Anamika Shuklas have been found working in KGBVs in Ambedkar Nagar, Baghpat, Aligarh, Saharanpur and Prayagraj districts. She has reportedly drawn a combined salary of Rs one crore in the past one year.

Teachers in KGBV, a residential setup for girls from weaker sections of the society, are appointed on contract and are paid approximately Rs 30,000 per month. Each block in a district has one Kasturba Gandhi school.

Basic Education Minister Satish Dwivedi said that the incident was 'shocking' and the police would unravel the entire racket in the case. "No officer, employee who connived with this teacher in providing her job at KGBV and subsequently hiding it, will be spared," he said.